Godavari Biorefineries secures European patent for biofiller technology

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • European Patent Office grants patent EP3313916 to Godavari Biorefineries on August 12, 2026
  • Technology develops a biodegradable biofiller to replace carbon black in rubber reinforcement
  • Applications span tyres, footwear, belts, and industrial rubber goods
  • Disclosure made under Regulation 30 of SEBI LODR Regulations, 2015
powered bylight_fuzz_icon
50140360

*this image is generated using AI for illustrative purposes only.

Godavari Biorefineries Ltd has been granted a European patent for its biofiller technology designed for rubber reinforcement. The European Patent Office issued the certificate on August 12, 2026.

The company disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted to the National Stock Exchange of India Limited and BSE Limited on September 5, 2026.

Patent Details

The granted patent, numbered EP3313916, covers an invention titled "A Biofiller for Rubber Reinforcement." The technology aims to provide an efficient, economic, and biodegradable alternative to conventional carbon black used in tyres and other rubber goods.

Parameter Detail
Patent Number EP3313916
Grant Date August 12, 2026
Authority European Patent Office
Technology Biofiller for Rubber Reinforcement

Application Scope

The biofiller is engineered to partially replace carbon black while maintaining or improving key mechanical properties. The invention includes a scalable manufacturing process suitable for industrial applications.

Potential use cases identified by the company include:

  • Tyres
  • Footwear
  • Belts
  • Bags
  • Other industrial rubber goods

The technology combines performance benefits with cost savings and environmental advantages, positioning it as a value-driven solution for the rubber industry.

Corporate Disclosure

Manoj Jain, Company Secretary and Compliance Officer of Godavari Biorefineries Limited, signed the disclosure letter. The company is headquartered at Somaiya Bhavan, Fort Mumbai, Maharashtra.

Historical Stock Returns for Godavari Biorefineries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.45%+1.07%-7.27%-13.28%-15.47%0.0%

What is the projected timeline for Godavari Biorefineries to scale up production of the biofiller for commercial supply to European tyre manufacturers?

How might this patent grant influence the company's valuation and stock performance in the near term given the shift towards sustainable materials?

Are there any existing partnerships or Memorandums of Understanding with major rubber or tyre companies that could accelerate the adoption of this technology?

like15
dislike

Godavari Biorefineries sets Sep 28 for 71st AGM; e-voting starts Sep 25

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Godavari Biorefineries holds 71st AGM on September 28, 2026, via video conferencing
  • Remote e-voting runs from September 25 to September 27, 2026
  • FY26 revenue rose to ₹1,96,492.02 lakh from ₹185,316.64 lakh in FY25
  • Company turned profitable with PAT of ₹123.62 lakh against prior year loss of ₹2,175.95 lakh
  • Finance costs fell nearly 32.4% to ₹4,844.57 lakh, driving the turnaround
powered bylight_fuzz_icon
50071262

*this image is generated using AI for illustrative purposes only.

Godavari Biorefineries has scheduled its 71st Annual General Meeting for September 28, 2026. The meeting will be held at 11:30 am via video conferencing. Remote e-voting commences on September 25, 2026, and concludes on September 27, 2026. Shareholders holding shares as on September 21, 2026 are eligible to vote.

The company dispatched the annual report for FY26 to eligible members on September 4, 2026. The document is also available on the company website. The agenda includes the adoption of audited financial statements and several special resolutions regarding board appointments and remuneration approvals.

Financial Performance

The company reported a significant turnaround in profitability for FY26 compared to the previous year. Revenue from operations rose to ₹1,96,492.02 lakh from ₹185,316.64 lakh in FY25.

Metric FY26 FY25
Revenue from Operations ₹1,96,492.02 lakh ₹185,316.64 lakh
PBDIT ₹13,453.40 lakh ₹11,606.18 lakh
Finance Costs ₹4,844.57 lakh ₹7,160.79 lakh
PAT (Before OCI) ₹123.62 lakh (₹2,175.95) lakh

Profit before depreciation, interest, exceptional items, and tax increased to ₹13,453.40 lakh from ₹11,606.18 lakh. Finance costs declined sharply to ₹4,844.57 lakh from ₹7,160.79 lakh, aiding the bottom line. The company returned to profit after tax, reporting ₹123.62 lakh against a loss of ₹2,175.95 lakh in the prior year.

What the Numbers Show

The shift from a substantial loss to a modest profit was driven primarily by a reduction in finance costs rather than an expansion in operating margins. While PBDIT grew by approximately 15.9%, finance costs fell by nearly 32.4%. This divergence suggests that interest cost management played a larger role in the turnaround than operational leverage during the period.

Board Appointments

The meeting will seek approval for the reappointment of Samir S. Somaiya as Managing Director for three years, effective April 1, 2027. His remuneration includes a basic salary of ₹17,95,360 per month and a commission of 2% of net profit.

Suhas Godage is proposed for reappointment as Whole-Time Director (Executive Director, Works-Sakarwadi) for three years starting April 1, 2027. His package includes a basic salary of ₹254,190 per month and a performance incentive capped at ₹20 lakh annually.

Dinesh Sharma will be appointed as a director and subsequently as Whole-Time Director (Executive Director, Works-Sameerwadi) effective from the date of the AGM. He currently serves as Chief Technical Officer at the Sameerwadi unit. His remuneration includes a basic salary of ₹255,030 per month.

Dr Raman Ramchandran and Suhas Godage are retiring by rotation and offer themselves for reappointment as directors.

Other Business

The company seeks ratification for the remuneration of cost auditor M/s R. Nanabhoy & Co., amounting to ₹6,40,000 per annum plus taxes for the financial year ending March 31, 2027.

Shareholders will also vote on contributing up to ₹1,40,00,000 to charitable and other funds in any financial year. Additionally, approval is sought for accepting fixed deposits from the public and members under three schemes offering interest rates between 8.50% and 9.50% per annum depending on tenure.

Historical Stock Returns for Godavari Biorefineries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.45%+1.07%-7.27%-13.28%-15.47%0.0%

Can Godavari Biorefineries sustain its profitability in FY27 if operating margins do not improve, given that the recent turnaround was primarily driven by reduced finance costs rather than operational efficiency?

How will the appointment of Dinesh Sharma as Whole-Time Director for the Sameerwadi unit impact the operational synergy and cost structures between the Sakarwadi and Sameerwadi facilities?

What are the strategic implications of approving fixed deposit schemes with interest rates up to 9.50% in the current macroeconomic environment, and how might this affect the company's overall debt servicing capacity?

like18
dislike

More News on Godavari Biorefineries

1 Year Returns:-15.47%